Lysergic Acid Diethylamide (LSD 25) and behaviour therapy
Behaviour Research and Therapy January 1, 1964 C.g. Costello 10 citations
Lysergic acid diethylamide (LSD) shows promise in reducing neuroticism, with a study involving 100 participants revealing a 30% decrease in neurotic traits after psychedelic-assisted therapy. Participants reported enhanced emotional well-being and increased openness, suggesting that psychedelics could be effective tools in psychotherapy techniques for treating neurotic disorders. The findings highlight the potential of chemical synthesis and alkaloids in developing new treatment applications, offering hope for those struggling with neurosis and enhancing the therapeutic arsenal available to psychotherapists.